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ABSTRACT
Feline immunodeficiency virus (FIV) infects many
species of cat, and is related to HIV, causing a
similar pathology. High-throughput selective 20 hy-
droxyl acylation analysed by primer extension
(SHAPE), a technique that allows structural interro-
gation at each nucleotide, was used to map the sec-
ondary structure of the FIV packaging signal RNA.
Previous studies of this RNA showed four conserved
stem–loops, extensive long-range interactions
(LRIs) and a small, palindromic stem–loop (SL5)
within the gag open reading frame (ORF) that may
act as a dimerization initiation site (DIS), enabling
the virus to package two copies of its genome.
Our analyses of wild-type (wt) and mutant RNAs
suggest that although the four conserved stem–
loops are static structures, the 50 and 30 regions pre-
viously shown to form LRI also adopt an alternative,
yet similarly conserved conformation, in which the
putative DIS is occluded, and which may thus favour
translational and splicing functions over encapsida-
tion. SHAPE and in vitro dimerization assays were
used to examine SL5 mutants. Dimerization
contacts appear to be made between palindromic
loop sequences in SL5. As this stem–loop is located
within the gag ORF, recognition of a dimeric RNA
provides a possible mechanism for the specific
packaging of genomic over spliced viral RNAs.
INTRODUCTION
Feline immunodeﬁciency virus (FIV) is a lentivirus which
causes pathology in its host similar to that of HIV in
humans (1–5). The virus has a worldwide distribution
and infects many feline species, including up to 22% of
domestic cats and 80% of African lions (6–8). FIV strains
are species speciﬁc, and were previously thought to have
milder effects upon big cats, but recent evidence refutes
this, with similar signs of disease observed across species
(9,10). Aside from being a common veterinary pathogen,
FIV infection of cats is a small animal model for acquired
immune deﬁciency syndrome (AIDS) (11) and FIV-based
vectors are under development for human gene therapy
(12). Despite increasing evidence of its profound patho-
logical impact on various feline species, including endan-
gered ones, and its potential therapeutic values,
understanding of the molecular biology of the virus is
relatively rudimentary. In order to utilize FIV to its full
potential, and to develop methods to combat its effect on
feline species, a greater understanding of its molecular
architecture is essential.
The transcribed unspliced RNA of retroviruses serves as
the viral genome and also encodes its core structural and
enzymatic proteins. Different lentiviruses may use the
same RNA molecule for both functions or separate
pools of RNA for translation or packaging (13). In
order to package its genome into assembling particles
during replication, the virus must speciﬁcally recognize
and capture its genomic RNA from within the cytoplasmic
pool of cellular and spliced viral mRNAs. This is mediated
in a highly speciﬁc manner by cis-acting packaging signals
that are recognized by the viral Gag protein. These se-
quences are often situated within the 50-end of the RNA
genome, whose structural context contributes to the rec-
ognition process (14,15).
Two non-covalently linked copies of the (+) strand
RNA genome are encapsidated into the virion. The
dimer linkage region is often in close proximity to, or
part of, the packaging recognition signal (16–18). Dimer
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stages, initiated by the interaction of a palindromic
sequence on the two strands to form a ‘kissing loop’
(19–24). This loop is at the tip of a stable helix which sub-
sequently unwinds to form an extended interstrand duplex
(25). Although it is clear that packaging and dimerization
are intimately linked processes, whether dimerization
begins prior to or following an interaction with the Gag
polyprotein remains a subject of debate (26–29).
In FIV, the ﬁrst 511nt of the genome are necessary and
sufﬁcient for optimal packaging, but within this, the virus
has an unusual, bipartite, packaging signal comprising the
ﬁrst 150nt of the 50 untranslated region (UTR) and the
ﬁrst 100nt of gag (30–34). The FIV packaging signal
region has been examined previously by us (35) and
others (36), providing contrasting structural models. Our
model shows ﬁve conserved stem–loops (SLs), including
one of around 150nt, and one small palindromic SL (SL5)
that is a candidate for the genome dimerization initiation
site (DIS), as well as extensive, conserved long-range inter-
actions (LRIs) linking the 50 and 30 regions. To resolve the
disparity between the published structures and to generate
more precise structural data on this RNA we used select-
ive 20 hydroxyl acylation analysed by primer extension
(SHAPE), a novel chemo-enzymatic probing strategy
which examines the ﬂexibility (a surrogate marker for
base-pairing) of the backbone at each nucleotide position
(37). SHAPE offers the advantage that all 4nt can be inter-
rogated with a single reagent, which readily reacts with
positions that are single-stranded. In contrast, nucleotides
that are base-paired or architecturally constrained are less
reactive.
Our results validate the structures of four stable SLs in
our original model, but suggest that the 50 and 30 interact-
ing regions can adopt alternative structures. In one of
these we conﬁrm formation of the conserved LRIs we
published previously, and in the alternative structure, a
series of small SLs is observed. The two separate mono-
meric conformers were visualized by native polyacryl-
amide gel electrophoresis (PAGE), and mutagenesis was
used to probe their structures, conﬁrming the two struc-
tural models. Previously, we also noted a unique palin-
dromic sequence in the gag region, SL5, which formed a
conserved helix loop and seemed a likely candidate for the
FIV DIS (35). We therefore performed dimerization
assays on a series of in vitro transcribed RNAs containing
mutations in this palindrome. Dimerization was reduced
following disruption of sequence auto-complementarity in
SL5, and SHAPE showed that nucleotides in the palin-
drome were rendered single-stranded, implicating SL5 as
the DIS. Only in the LRI structure is this palindromic DIS
accessible to form kissing–loop interactions that can
promote the dimerization process, as it is base-paired in
the alternative structure. Dimerization assays using
LRI-stabilizing and destabilizing mutants support this.
This conformational switch between two structures resem-
bles the model proposed in HIV (38,39) in which the DIS
can adopt an occluded or accessible conﬁguration, sug-
gesting a mechanism for regulating the monomer/dimer
equilibrium in order to facilitate packaging of dimeric
RNA over a non-dimerizing monomeric template suited
for translation. Our alternative, monomeric structure is
less stable than the dimerization-competent structure
( 145kcal/mol versus  181kcal/mol) which would facili-
tate translation.
MATERIALS AND METHODS
Preparation of in vitro transcribed RNAs
DNA template corresponding to the ﬁrst 511nt of the FIV
RNA genome and containing the T7 RNA polymerase
promoter was prepared by polymerase chain reaction
(PCR) using primers 1 (F) and 511 (R) from template plas-
mid TR394 (40) as previously described (35), or from
mutant plasmids as described in the ‘Results’ section. An
extended template for SHAPE was constructed using
primer 1 (F) and 711 (R, CAC CGT CAT ATT TAA
AAG TCC). Templates of varying length were constructed
for dimerization analysis using forward primers 1 and 143
(TAA TAC GAC TCA CTA TAG GCG CCC GAA
CAG GGA C) and reverse primers 95 (GAT TAC ACA
GAT ACT CGA CAG G), 146 (CGC CAA CTG CGA
AGT TCT CGG), 321 (CTG GGC CTT TAA ACA ATG
AC), 342 (GAG TCA CCA GAT GTA ATT TAT C), 381
(CTG TCC CTC GGC GAA TCT C), 484 (CCC CTA
CTC CTA CAG CAA C), 511 and 564 (CAC CAG GTT
CTC GTC CTG TAG). Primer numbers represent the
nucleotide position according to the genomic RNA of
the 50 (F primers) or 30 (R primers) ends of the transcript
they produce. PCR products were puriﬁed from 1%
agarose gels using Qiagen Gel Extraction kits, according
to the manufacturer’s protocol. Puriﬁcation of in vitro
transcribed RNA followed one of two protocols. Firstly,
20ml reactions contained 7.5mM rNTPs (Ambion),
1  buffer (Megashortscript buffer, Ambion), 2mgt e m p l a t e
DNA and 2ml T7 RNA polymerase (Megashortscript
enzyme mix, Ambion) and were incubated for 4h at 37 C.
DNA was degraded with 4U DNase (turboDNase,
Ambion) for 20min at 37 C, and the size and integrity of
RNA transcripts was veriﬁed by electrophoresis on 1%
agarose gels before puriﬁcation on ﬁlter cartridges
(MegaClear, Ambion) and elution in H2O. Large-scale
transcription reactions contained 6mM of each rNTP
(Promega), 40mM DTT, 0.5U/ml yeast inorganic pyro-
phosphatase (NEB), 60U/ml RNase inhibitor (RNAsin
Plus, Promega), 4.23mg/ml T7 RNA polymerase (courtesy
of J. Miller, National Cancer Institute, USA), 126nM
DNA template, 80mM HEPES-KOH pH 7.6, 12mM
MgCl2, 2mM spermidine, 0.01% Triton X-100 in a
volume of 15–30ml and were incubated at 37 C for 16h.
A further 4.23mg/ml T7 RNA polymerase, 0.5U/ml yeast
inorganic pyrophosphatase and 10mM MgCl2 were added
and incubated for 3h at 37 C. DNA was digested with
15U/ml DNase (RQ1 RNase free DNase, Promega) for
2h at 37 C. Transcriptions were clariﬁed by centrifugation
at 10000g for 45min and concentrated to 4mL using
Amicon Ultra Ultracel centrifugal concentrators accord-
ing to the manufacturer’s instructions. RNA was puriﬁed
by denaturing PAGE on 10% gels at a constant tempera-
ture of 50 C, before visualization by UV-shadowing.
Electroeluted RNA was precipitated with 0.3M sodium
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covered by centrifugation, washed with 70% ethanol, dried
and resuspended in sterile H2O. Concentrated RNA was
stored at  20 C.
Mutagenesis
Mutants AN14, AN20, AN21 and AN26 were prepared as
described (41). Mutant AN40 was prepared from plasmid
TR394 using primer GAA CCC TGT CGA GTA CCC
ATG TAA TCT TTT TTA CCT GTG AGG TC and its
reverse complement and the Quikchange II mutagenesis
kit (Stratagene), according to the manufacturer’s instruc-
tions. The resulting plasmid was veriﬁed by sequencing.
Selective 20hydroxyl acylation analysed by primer
extension
Ten picomoles of RNA were resuspended in 20ml1 0m M
Tris pH 8, 100mM KCl and 0.1mM ethylenediaminete-
traacetic acid (EDTA), heated at 95 C for 3min and
cooled on ice. RNA was refolded by adding 150mlo f
40mM Tris pH 8, 4mM MgCl2, 0.2mM EDTA,
130mM KCl and 12U RNase inhibitor (Superasein,
Ambion) for 10min at 37 C. Alternatively, RNA was
probed immediately following transcription and column
elution, as for previous RNase mapping experiments
(35). Reactions were divided into two 72ml aliquots and
8ml 40mM of SHAPE chemical reagent 1M7 or NMIA in
dimethyl sulphoxide (DMSO) was added to one. To the
other aliquot, 8ml of DMSO was added. To examine di-
merization, 1M7 in DMSO or DMSO only were added to
a ﬁnal concentration of 4mM after the 4-h incubation (see
in vitro dimerization assay method below). Tubes were
incubated at 37 C for 2min and RNA was precipitated
at  20 C with 60ng/ml glycogen, 0.3M sodium acetate
pH 5.2 and 3vol of cold ethanol. Precipitated RNA was
collected by centrifugation, washed once in 70% ethanol
and resuspended in 5ml 5mM Tris pH 8, 0.1mM EDTA.
Five picomoles of Cy5 or 6FAM-labelled (for SHAPE
reagent modiﬁed samples) or WellRed D3 or VIC-
labelled (for unmodiﬁed samples) primer 511 or 384 (35)
in 7mlH 2O were annealed to the RNA at 85 C for 1min,
60 C for 5min and 35 C for 5min. RNA was reverse
transcribed at 50 C for 20min with 100U RT
(Invitrogen superscript III), 1  RT buffer (Invitrogen),
5mM DTT and 500mM dNTPs (Promega). RNA was
hydrolysed with 200mM NaOH for 5min at 95 C and
reactions were neutralized with an equivalent amount of
HCl. Sequencing ladders were prepared using the
Epicentre cycle sequencing kit according to the manufac-
turer’s instructions and primers labelled with WellRed D2
and LicorIR-800 or NED and PET dyes. Modiﬁed
and control samples were mixed with the sequencing
ladders, precipitated as above, dried and resuspended
in 40ml deionized formamide. Primer extension prod-
ucts were analysed on a Beckman CEQ8000 Genetic
Analysis System or an Applied Biosystems 3730xl DNA
analyser. Electropherograms were processed using the
SHAPEﬁnder programme, following the software develop-
er’s protocol and included the required pre-calibration for
matrixing and mobility shift for each set of primers (42).
1M7 or NMIA reactivity at each nucleotide position was
normalised as described (43). Brieﬂy, the area under each
negative peak was subtracted from that of the correspond-
ing positive peak. The resulting peak area difference at
each nucleotide position was then divided by the average
of the highest 8% of peak area differences, calculated after
discounting any results greater than the 3rd quartile plus
1.5  the interquartile range.
In silico modelling
Minimal free energy modelling was performed using
RNAstructure software (44) and illustrated using
XRNA. QGRS mapper was used to identify potential
G-quadruplexes.
Non-denaturing PAGE
RNAs were mixed with 1/6 volume of native loading
buffer (40% (v/v) glycerol, 44mM tris-borate pH 7,
0.25% orange G dye) and separated by electrophoresis
at 100V for 6h on gels containing 3.5% polyacrylamide
and 1  TBE (89mM Tris base, 89mM boric acid, 2mM
EDTA). Gels were subsequently stained for 10min with
1.3mM ethidium bromide in 1  TBE
In vitro dimerization assay
Five-hundred nanograms of in vitro transcribed RNA in
10ml, 10mM Tris–HCl, pH 7, 200mM NaCl, 4mM
MgCl2 was incubated at 95 C for 2min, 4 C for 2min
and 55 C for 4h, in a thermocycler before the addition
of 1/6 volume native loading buffer, as above, and elec-
trophoresis through 1% agarose 1  TBE or TBM (89mM
Tris base, 89mM boric acid, 0.7mM MgCl2) gels contain-
ing 1.3mM ethidium bromide in the corresponding buffer,
at room temperature.
RESULTS
SHAPE data conﬁrm the structures of SL1-4
SHAPE has been recently developed to study RNA sec-
ondary structure (37) by examining the ﬂexibility of the
RNA backbone (which depends on base-pairing) at each
nucleotide position via reactivity with a speciﬁc adduct
(1M7 or NMIA). We ﬁrst applied this technique to the
wt FIV packaging signal RNA in order to validate our
previous model, examine the conformational stability of
individual helices, and identify potential LRIs that could
have been overlooked by chemo-enzymatic methods that
probe only speciﬁc nucleotides and structures. Previous
studies had mapped the FIV packaging signal to within
a 511-nt element spanning the 50 UTR and the ﬁrst 100nt
of gag (31). Although LRIs may exist with parts of the
genome further 30, this region alone was shown to be both
necessary and sufﬁcient for optimal packaging, and hence
must contain all required structures. Therefore, we chose
to examine the structure of the 50 511nt in isolation.
Reactivity to the SHAPE reagent 1M7 at each nucleo-
tide position is shown on Figure 1, in the context of our
original model, to assess its validity. Numerical data are
given in Supplementary Figure S1. The most reactive, and
6694 Nucleic Acids Research, 2011,Vol.39, No. 15Figure 1. SHAPE analysis of the FIV packaging signal RNA. In vitro transcribed RNA was modiﬁed with 1M7, reverse transcribed using
ﬂuorophore-labelled primers and separated by capillary electrophoresis. Nucleotide positions were determined using G and U sequencing ladders.
1M7 reactivity at each nucleotide position was determined by subtraction of the reverse transcription product of unmodiﬁed RNA from that of
1M7-modiﬁed RNA, using SHAPEﬁnder software. Nucleotide reactivities are colour-coded as shown in the key. Reactivities of the 30-end were not
determined (shown in grey). The RNA is drawn in our previously published secondary structure, to ascertain its validity. Nts are numbered with a
dash every 10nt. (A) In vitro transcribed packaging signal RNA; 511nt. (B) In vitro transcribed SL2 RNA. Data shown are an average of at least two
independent experiments.
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a reactivity >0.9U and are shown in red. Nucleotide pos-
itions with reactivity <0.3U (indicative of fully base
paired or otherwise structurally constrained bases) are in
black, and nucleotides of intermediate reactivity are
colour-coded according to the key. Reactivities of the 30
nucleotides (G466-A511) were not determined at this
stage. Data shown are an average of two or three experi-
ments. Typically the data for any individual nucleotide
varied by no more than 0.1U between experiments,
with a Pearson correlation coefﬁcient that was typically
0.8–0.9.
Overall, the SHAPE data support our original model
(Figure 1A); this is particularly the case for SLs 1–4. The
loops of these four regions contain the most highly
reactive, exposed nucleotides. The remainder of the most
highly reactive nucleotides are situated in bulges, internal
loops, single-stranded regions linking SLs and the closing
pairs of helices, with the exception of G 90, U101 and
A320. The tip of SL5 contains mainly unreactive nucleo-
tides, possibly indicating kissing–loop interactions invo-
lved in dimer initiation. Nucleotides that were predicted
to be base-paired in SL1 were unreactive to 1M7, with the
exception of A131. As the A residue 30 of this was pre-
dicted to be bulged, and is unreactive, it is likely that the
bulge forms consistently at A131 and not at A132 (shown
in Figure 2). Predicted base-paired nucleotides in SL2 are
relatively unreactive, except for closing pairs and G-U
pairs. The exceptions are nucleotides U244–G246, which
are highly reactive; this may indicate that the internal loop
30 of this is larger and includes these nucleotides.
Structural predictions using the RNA structure pro-
gramme (44) and 1M7 reactivities as pseudo free-energy
constraints suggest that this is the case in the alternative
structure (shown in Figure 2). Minimal free energy predic-
tions suggested that the SL2 structure is maintained inde-
pendently of adjacent sequences. To validate this
hypothesis and search for LRIs that the single-stranded
regions of SL2 may form with other areas of the
packaging signal, we transcribed SL2 RNA independ-
ently, examined its 1M7 reactivity, and compared
the data with SL2 in the context of the 511-nt RNA
(Figure 1B). Nucleotide reactivities are broadly similar
across SL2, whether analysed alone or in the context of
the extended 50 and 30 structure, suggesting that SL2 forms
independently of 50 and 30 sub-domains, i.e. independent
of LRIs. Subtle differences in nucleotide reactivity were
noted between the structures shown in Figure 1A and B,
which may reﬂect minor experimental variation.
SHAPE data provide alternative structures 50 and 30 of
SLs1–4
The intermediate 1M7 reactivity between regions 50 of SL1
and 30 of SL4 was higher than anticipated for paired nu-
cleotides. This was particularly evident between nucleo-
tides 61 and 105. The high G-U content of three of these
helices, as well as single and double-strand speciﬁc enzym-
atic cleavage, led us to propose previously that they were
metastable, and opened and closed by ‘breathing’, thereby
allowing access to both single and double-strand speciﬁc
nucleases (35). However, disparity between 1M7 reactivity
between the 50 and 30 side of some of the proposed helices
seen in Figure 1A requires an alternative explanation.
The 50 and 30 regions can simultaneously adopt two
different conformations
Possible alternative RNA conformations which would
account for disparity in observed and expected 1M7
reactivities of the LRI regions were examined, using the
SHAPE data as pseudo free-energy constraints in the
RNAstructure programme (44). Although three structures
that correspond more accurately to the SHAPE data were
predicted (data not shown), no individual structure was
fully conﬁrmatory, and no individual structure convin-
cingly satisﬁed both SHAPE and our previous biochem-
ical data, which had been observed under similar
conditions. The secondary structural model of Figure 1A
is supported by strong phylogenetic evidence (69% of
nucleotides in the 50/30 interacting regions that vary in
sequence between FIV isolates maintain the ability to
base-pair), and by our probing data, as all enzymatic
cleavage sites in this region mapped accurately onto the
model (35). We therefore sought an alternative structure
of the 50 and 30 regions that could be present simultan-
eously with the LRI structure shown in Figure 1A, and
would reconcile both the RNase mapping and the SHAPE
data. One of the three predicted structures fulﬁls these
criteria and is shown in Figure 2. SLs 1–4 are maintained,
but the LRI region adopts a series of further SLs,
designated SL A–E. A mixture of these two structures
would account for the disparity in nucleotide reactivity
between 50 and 30 sides of the LRI region, as in one struc-
ture (Figure 1A), most nucleotides are paired, whereas
in the other, multiple SLs (MSL) (Figure 2), most 30 nu-
cleotides remain paired in an alternative conformation,
whereas many of the 50 nucleotides remain single
stranded. With a few exceptions, highly reactive nucleo-
tides are single stranded in both structures, whereas those
that are single stranded in only one of the two structures
exhibit intermediate 1M7 reactivity. Some areas are shown
as single stranded in one of the two structures but exhibit
little to no 1M7 reactivity, notably the regions connecting
SL1–4, and loop nucleotides C402–A409. Although
SHAPE data maps more accurately onto the 50 and 30
regions of the MSL structure (Figure 2) than the original
LRI structure (Figure 1), it does not fully ﬁt the data, and
ﬁts our previous enzymatic data less well (7/27 single-
stranded cleavage sites map to nucleotides that have
Watson–Crick base pairs and in are the middle of
helices. 2/20 RNase CV1 cleavage sites are in the middle
of a long single-stranded region), suggesting that structure
2 is not present on its own. A mixture of both structures
accurately accounts for all the SHAPE and enzymatic
data.
Since there were some differences in RNA preparation
and puriﬁcation methods between our enzymatic (35) and
SHAPE studies, it was important to determine whether
these favoured different RNA conformations, or
whether both structures were formed under each condi-
tion. NMIA reactivity proﬁles for RNA prepared by the
6696 Nucleic Acids Research, 2011,Vol.39, No. 15two methods are very similar (Supplementary Figure S2),
eliminating the method of preparation as promoting dif-
ferent structures. Small differences in absolute reactivity
do exist, as might be anticipated in such a large data set.
The nucleotides that vary most in reactivity are
single-stranded, non-canonically paired, or adjacent to a
single-stranded or non-canonically paired nucleotide. This
variable reactivity proﬁle has been observed by those who
Figure 2. Alternative (MSL) structure of the FIV packaging signal. 1M7 reactivities determined as before were used as pseudo free-energy con-
straints in a minimal free energy folding algorithm (RNAstructure). Nucleotide reactivities are colour-coded as shown in the key and numbered with
a dash every 10nt.
Nucleic Acids Research, 2011,Vol.39, No. 15 6697developed the SHAPE technique, as the standard devi-
ation is much higher for such nucleotides than for those
canonically paired and nested within helices (43,45,46).
Crucially, each data set shows the same pattern of reactiv-
ity and supports the presence of the two predicted mono-
meric conformations.
In the event that structural data for the 30 50nt thus far
unmapped did not ﬁt our models and suggested alterna-
tive structures, we examined the SHAPE reactivity of this
region, and the 50-end of a 711-nt transcript. NMIA sen-
sitivity of the 50-end of a 511-nt (data not shown) and
711-nt transcript was very similar. Reactivities of the 50
and 30-ends of the ﬁrst 511nt of the longer transcript are
illustrated in Supplementary Figure S3, supporting a
mixture of the LRI and MSL structures. Again, most dif-
ferences in absolute reactivity between the data sets
(Figures 1 and 2 versus Supplementary Figure S3) are
located at single-stranded or non-canonically paired nu-
cleotides, or those adjacent to them, and are likely to be a
reﬂection of their previously documented variability of
reactivity to 1M7 and NMIA (45). Importantly, each
data set independently supports the presence of each of
the two predicted conformers. The intermediate to high
reactivity of the 30-end is likely to be because this region
is single-stranded in the MSL conformation. However, it
could be due to the unpredictable reactivity of G-U pairs,
or, because of the high number of G-U pairs in this helix,
its metastability may contribute to the SHAPE reactivity
seen.
The two monomeric conformations can be separated by
non-denaturing PAGE
To visualize the two proposed structures we fractionated
the RNA on a 3.5% non-denaturing polyacrylamide gel.
Two distinct bands were evident around the expected
monomeric size of 511nt, regardless of the RNA prepar-
ation method (Figure 3A, lanes wtS and wtT). In order to
selectively stabilize the MSL structure, we examined the
structure of a mutant, AN14 (41), which disrupts a
conserved heptanucleotide helix in the LRI form but
should not affect the stability of SLB in the MSL form
(Figure 3B). Conversely, to stabilize the LRI form, we
mutated 3nt in the SLB helix, such that it should be se-
lectively destabilized in the MSL conformer (AN40,
Figure 3B). Analysis of these mutants by non-denaturing
PAGE shows a decrease in the amount of slower-moving
relative to faster-moving conformer in the AN14 mutant
RNA, and vice versa in the AN40 RNA (Figure 3A).
Densitometric analysis of multiple samples shows the
changes in ratio to be statistically signiﬁcant (P<0.01)
(Figure 3C). Dimeric RNA would be expected to
migrate at around 1000nt, but could be detected only as
a very faint band in all samples (data not shown).
AN14 and AN40 mutants were next analysed by
SHAPE. As evident in Figure 3A and C, a small portion
of AN14 still adopts the LRI-like conformer, and likewise
a small portion of the AN40 RNA assumes the MSL-like
conformer. However, as the ratio of each structure differs
greatly between the two mutants, we reasoned that this
should be reﬂected in the NMIA reactivity. There was
no difference in reactivity of the more static structures
SLs 1–4 (data not shown), but as expected the 30-end
shows varying NMIA sensitivity, reﬂecting the ratios of
the two conformers (Figure 3D). Reactivity of the AN40
mutant is low across the expected LRI regions of the LRI
structure, with increased reactivity in the connecting
loops. Nucleotides 436–438 are within an LRI, but have
become more reactive, which is likely to be a reﬂection of
the G-U pairs they form in this conformation. Reactivity
of non-canonical base pairs is unpredictable, variable, and
can be very high (45). NMIA reactivity of AN14 is low in
the stem regions and higher in the loop regions of the
MSL structure. The 30 side of the highly conserved
heptanucleotide forming the helix at nts 422–428 is
highly reactive when its 50 complement is mutated to a
non-complementary sequence in AN14 (nts 425–428,
AN14 Figure 3D). Although these 4nt are also paired in
the MSL conformer, they are non-canonically paired or
adjacent to such pairs, rather than paired in a 7-bp helix
containing entirely Watson–Crick pairs as they are in the
LRI conformation, and hence reactivity to NMIA could
be expected to increase. Reactivity of the SL5 region also
drops slightly in AN14, where it is predicted to be stably
base-paired as part of SLE.
The alternative SLs and helices are structurally conserved
between FIV isolates
Previously, we showed that theR N As t r u c t u r eo fF i g u r e1 A
is highly conserved between 76 FIV isolates. The ability
of these domestic cat strains of FIV to form the MSL
structure was assessed using our previously published
alignment (35), and is illustrated in Figure 4, which
shows nucleotides that vary in sequence but maintain
the ability to base-pair in all isolates. A more detailed
analysis, indicating the degree of sequence variation of
each nucleotide, is shown in Supplementary Figure S4.
Helices of SLs A and B assume an identical structure in
all isolates, while those of sSLs C, D and E form identi-
cally in the majority, as do those joining the 50 and 30-ends.
SL5 acts as a DIS in vitro
Retroviruses package two copies of their RNA genome,
linked as a dimer (16,18). Dimerization begins at the DIS,
which is usually found in the 50UTR and is often a palin-
dromic sequence. Although SL5 is within the gag open
reading frame (ORF), it contains the only conserved pal-
indrome in the FIV packaging signal RNA, making it a
credible candidate for the DIS. The SL5 helix loop is the
only exposed sequence capable of assuming an initial
‘kissing loop’ interaction. This interaction also has the
potential to promote an extended dimer, since minimal
free energy structural modelling of two copies of the
FIV packaging signal produced structures linked at the
SL5 palindrome, with the region extending 30 of this inter-
acting with the 50 region of the other strand
(Supplementary Figure S5). All structures generated by
the prediction algorithm were based on the LRI model
of Figure 1A, with minor differences in internal loops
and bulges (data not shown).
6698 Nucleic Acids Research, 2011,Vol.39, No. 15Figure 3. Analyses of the two conformers by non-denaturing PAGE and SHAPE. (A) FIV packaging signal RNA was electrophoresed on a
non-denaturing polyacrylamide gel and visualised by ethidium bromide staining and UV illumination. L; RNA ladder wtS; denatured and renatured
wt RNA. AN14; denatured and renatured AN14 RNA. AN40; denatured and renatured AN40 RNA. wtT; wt RNA probed after transcription and
column puriﬁcation. (B) Schematic diagram showing the effects of AN14 and AN40 mutations upon: (Bi) the LRI structure; (Bii) SLB of the MSL
structure. (C) Densitometric analysis of the ratio of slower-migrating to faster-migrating conformer. Data represent an average of at least six
independent experiments. Stars represent statistical signiﬁcance relative to wt (P<0.01) by t-test. Error bars show the S.E.M. (D) NMIA reactivity
proﬁle of the 30 portion of each mutant RNA from nts 380–460. Upper panel, AN14; lower panel, AN40. Grey boxes indicate the location of various
structural features of each mutant. Reactivity >4 is shown as 4. Numbers below the graph represent the number of the initial nucleotide of each helix
in the LRI structure. Data shown are an average of three independent experiments.
Nucleic Acids Research, 2011,Vol.39, No. 15 6699In order to determine whether SL5 might function as
the DIS, we performed dimerization assays with a panel of
mutants in which SL5 was replaced with either a
non-palindromic sequence or an alternative palindrome.
Figure 5 shows the results of this assay. Wild-type RNA
migrated as two species of  500 and 1000nt, correspond-
ing to the expected size of monomer and dimer species
(Figure 5A). Replacing the SL5 sequence with an alterna-
tive palindrome also leads to dimer formation (Figure 5A,
AN26). However, disrupting the palindromic nature of
SL5 by deletion of 5nt (AN20) or by inserting a
non-palindromic sequence of equal length (AN21)
abolishes dimer formation. Densitometric analysis of
multiple gels is shown in Figure 5B and conﬁrms that
there is a statistically signiﬁcant difference (P<0.01)
between wild type and mutants without a palindromic
sequence at SL5, but that there is not a statistically sig-
niﬁcant difference in ability to dimerize when SL5 is
replaced with an alternative palindrome. Similar results
in both TBM and TBE gels (Figure 5B) suggest formation
of so-called ‘tight dimers’ (47). In order to visualize the
Figure 5. Dimerization analysis of SL5 mutants. (A) Dimerization assay and 1M7 reactivity of SL5 mutants. In vitro transcribed FIV packaging
signal RNAs containing a wt or mutant SL5 sequence were heated to 95 C, snap-cooled, and incubated at 55 C for 4h in 10mM Tris–HCl, pH 7,
200mM NaCl, 4mM MgCl2 before electrophoresis on an agarose gel in TBM, or SHAPE analysis as described in ‘Materials and Methods’ section.
Mutant designations are given above the relevant lanes and their sequences at SL5 are illustrated above or below each lane. L; RNA ladder.
Nucleotide colours show 1M7 reactivities as shown on the key. (B) Densitometric analysis of dimerization on TBM (black bars) or TBE gels (striped
bars). Stars represent statistical signiﬁcance relative to wt (P<0.01) by t-test. Error bars represent the S.E.M.
Figure 4. Structural conservation of the 50- and 30-ends of the MSL
structure. Sequence variation was previously assessed using an align-
ment of 76 strains of domestic cat FIV. The ability of each strain of
FIV to form this MSL structure was determined using this alignment.
Grey nucleotides represent those which vary in sequence but maintain
the ability to base pair in 100% of isolates. SLs 1–4 are not shown.
6700 Nucleic Acids Research, 2011,Vol.39, No. 15structural differences between SL5 mutants, SHAPE was
performed by reaction of the RNA with 1M7 immediately
after the 4h incubation at 55 C, and reverse transcription,
capillary electrophoresis and analysis as before (see
‘Materials and Methods’ section). In the wild-type RNA,
1M7 reactivity is very low across the central 8nt of the
palindrome, indicating these are most likely base-paired
(Figure 5A, WT) which they would be in either the
kissing loop model of the LRI structure or in the mono-
meric MSL structure (Figure 2). 1M7 reactivities remain
low across the central 8nt when an alternative palindrome
is present (Figure 5A, AN26). However, nucleotides
display increased 1M7 reactivity when the palindrome is
disrupted (Figure 5A, AN20 and AN21), indicating loss of
base pairing. Reactivity of nucleotides outside these
regions is similar (data not shown). Further in vitro dimer-
ization experiments showed that deletions from the 30-end
of the packaging signal RNA abrogated dimerization
upon loss of SL5, and that the 50 side of the LRI region
was also necessary (Supplementary Figure S6). Such data
argue not only that SL5 acts as the DIS, but also that the
LRI structure is a necessary prerequisite for dimerization.
The palindrome at SL5 must be exposed in order to
promote dimerization in vitro
As the SL5 sequence promotes dimerization, and AN40 is
more likely to fold into a conformation that exposes SL5,
it should dimerize more readily. Conversely, as AN14 is
more likely to fold into a structure in which the DIS is
occluded, it should dimerize less readily. This was
observed in both TBM (Figure 6A and B) and TBE gels
(Figure 6B). There is a statistically signiﬁcant (P<0.01)
increase in the ratio of dimer to monomer in the AN40
RNA relative to wild type and a statistically signiﬁcant
(P<0.01) decrease in the ratio of dimer to monomer
observed in AN14.
DISCUSSION
Applying the chemo-enzymatic probing technique SHAPE
to the FIV leader has extended our previous work by re-
vealing new insights and resolving areas of uncertainty
within this RNA. In particular, an alternative structural
model with practical functional implications for this im-
portant region of the FIV genome is proposed here. Thus,
we have both extended our understanding of FIV RNA
cis-acting signals affecting packaging and illustrated add-
itional utilities of this probing technique.
Applying SHAPE to the FIV packaging signal structure
revealed only minor differences from our LRI model of
SLs 1–4 (compare Figures 1A and 2). SL1 differs in the
exact position of the 30 A bulge; A131 is unreactive,
whereas A132 is not. In the LRI model, this bulge was
modelled purely by minimal free energy, in silico, predic-
tions, as neither nucleotide was targeted by the enzymes or
chemicals previously used (35). Hence, it is likely that this
bulge is consistently located at A131. SL2 structure is vir-
tually identical to that of the LRI model, with minor dif-
ferences in the internal loops around nts A200 and A250.
According to SHAPE data, the loop at A250 includes the
2bp above it. Due to the extremely high 1M7 reactivity of
the 30 side of these pairs, and the absence of nuclease CV1
cleavages and structural conservation of the U-A pair
shown previously, the SHAPE-derived structure is likely
to be more accurate. The internal loop around nucleotide
A200 is suggested by SHAPE to comprise two smaller
loops separated by two A-U pairs. These nucleotides vary
from unreactive to highly reactive, and some were previ-
ously shown to be RNase A-sensitive, indicating single-
stranded pyrimidines. Lack of structural conservation of
these pairs suggests that they do not consistently form
(35). When SL2 is transcribed in isolation 1M7 reactivity
of most nucleotides is similar, indicating it is stable outside
the context of the entire packaging signal RNA. The
largest differences were found in the loop around nucleo-
tide A200 and in the helix above it. When the adjacent 50
and 30 regions are absent, there is a slight decrease in 1M7
reactivity of the upper 50 side of the loop, and an increase
in reactivity in the lower 50 side of the loop as well as the 50
side of the helix above it, suggesting a stabilizing inﬂuence
of the 50 and 30 regions. It is possible that there are
long-range interactions involving a small number of nu-
cleotides in the 50 side of this loop. SL3 appears to form
identically in both models, with metastability of the helix.
SL4 is extended at the base in the MSL model.
The area between SL1 and SL2, which contains the
primer binding site, was previously shown to be targeted
Figure 6. Dimerization of AN40 and AN14 mutants. Wt, AN40 or
AN14 RNA underwent dimerization as described in Figure 5, and
the percentage of dimers and monomers was visualized by electrophor-
esis on 1% agarose gels in TBM or TBE. (A) Representative TBM gel.
L; RNA ladder. (B) Densitometric analysis of the ratio of dimer to
monomer in wt, AN40 or AN14 RNAs in TBM (black bars) or TBE
gels (striped bars). Asterisks represent statistical signiﬁcance relative to
wt by t-test (P<0.01). Error bars represent the SEM.
Nucleic Acids Research, 2011,Vol.39, No. 15 6701by multiple single strand-speciﬁc enzymes (35), but exhibits
low 1M7 reactivity. It is possible that in the structural
form where the primer binding site (PBS) is single-
stranded, backbone ﬂexibility in this region is limited by
non-Watson–Crick interactions, which could affect the en-
zymatic and SHAPE reagents differently. Another region
of low 1M7 reactivity is the loop at nts C402–A409. In this
case, non-Watson–Crick interactions may also stabilize
the backbone, or alternatively, 50 CUACA 30 may form
a pseudoknot with nucleotides 456–460: 30 GAUGU 50.O f
the 61 strains of FIV for which there is sequence data for
both of these regions, 57 have these sequences, one
contains G at position 404 which could pair with U458
and three have single-nucleotide mutations that would not
pair (35). Regions of low 1M7 reactivity at the bases of
helices may be due to stacking interactions.
Both the intermediate 1M7 reactivity and a comparison
of SHAPE results with enzymatic probing data, suggest
that the 50 and 30 regions assume alternate structures.
Minimal free-energy modelling using SHAPE data as
pseudo free-energy constraints generated an alternative
structure to resolve this. Native PAGE analysis and inter-
rogation by mutagenesis and SHAPE indicate that the
RNA adopts alternate monomeric conformations that
could be stabilized into the LRI or MSL forms.
Phylogenetic evidence for the ability of the RNA to
assume alternate structures lies not only in their structural
conservation between various FIV isolates, but also the
fact that sequence conservation of the nucleotides that
pair ‘differently’ in each structure is higher than that
of those which pair ‘identically’ (35). Of the paired
nucleotides in SLs 1–4, 39% vary in >5% of isolates.
Despite this poor degree of sequence conservation, there
is an exceptionally high degree of structural similarity
between the isolates. Of the nucleotides that are paired
differently in both structures, only 9% vary in more
than 5% of isolates, indicating selective pressure to
maintain these sequences. Although a higher degree of
conservation might be expected for the 30 sequences, as
they lie within the gag coding region, the degree of
sequence conservation is just as high within the 50 inter-
acting region, which is untranslated, indicating strong se-
lective pressure to maintain both sequences. This would be
expected if the same RNA formed two structures, since in
most positions, simultaneous mutations would be neces-
sary to preserve both structures. Many helices in the 50/30
interacting regions are G-U rich, which could be function-
ally important if one molecule of RNA has to switch
between structures during the viral lifecycle.
Interestingly, in one of these conformations (LRI), the
proposed DIS is exposed, while the AUG start codon is
in the middle of a 7-bp helix, and the free energy of the
overall structure is lower (G= 181kcal/mol), possibly
favouring dimerization and packaging over translation.
The overall analysis suggests that the primer binding site
is unpaired and accessible for transfer RNA (tRNA)
primer binding which would also be important for subse-
quent reverse transcription of the genomic RNA after
infection.
In the other (MSL) structure, the DIS is occluded, the
gag AUG is in a small, 3-bp SL, and the structure on the
whole is less stable (G= 145kcal/mol), possibly
Figure 7. Accessibility of the functional elements in each structure. Schematic drawing showing the accessibility of the DIS, poly(A), major splice
donor (mSD), PBS and gag AUG in the original LRI structure (left) and MSL structure (right).
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The primer binding site is also occluded. The existence of
two structures in the FIV 50 region provokes comparison
with a structural switch mechanism previously proposed
for HIV-1 (38,39), and is schematically illustrated in
Figure 7. In support of this, the AN14 mutant was
recently shown to have impaired packaging (41), and is
shown here to have impaired dimerization in vitro, and
dimerization is enhanced when the RNA is stabilized in
the LRI form.
The palindromic sequence of SL5 is exposed in only one
of these structures. In vitro dimerization assays show that
a palindromic sequence at SL5 is necessary for dimer for-
mation, and that the dimers formed are tight dimers. 1M7
reactivity of these nucleotides under conditions favouring
dimerization suggest that the region is double-stranded
when a palindrome is present, and that nucleotides
remain single-stranded when non-palindromic sequences
are substituted. Thus, SL5 appears capable of
participating in a loop–loop intermolecular interaction
consistent with the kissing loop model of dimer initiation.
HIV and other retroviruses studied to date contain the
DIS in their 50 UTR, and although retroviruses have
been shown to selectively package a dimeric genome,
whether dimerization occurs before or after Gag binding
is not clear (16,48,49). The FIV DIS is located within the
gag ORF, restricting the ability to dimerize efﬁciently to
full-length genomic RNA and thus suggesting a potential
packaging mechanism.
This model would also explain the requirement for two
separate regions of the RNA for packaging (34), as these
stabilize the RNA in the LRI model, exposing the DIS.
Not only did successive 30 truncations of the RNA fail to
dimerize efﬁciently once the DIS sequence was no longer
present, but in vitro transcribed packaging signal RNA
with SLs 2–4 and the 30 side of the LRI region intact
(and hence the DIS), and the 50 side deleted, also failed
to form dimers as efﬁciently (Supplementary Figure S6B,
143F 511R).
The alternative FIV packaging signal structure pub-
lished previously by another group differs from ours except
in the structures of SL1, SL3 and SL4 (36). SHAPE data
presented here lend further support to the existence of SL2
as a large, stable SL, which in the James and Sargueil
model forms four separate SLs (36). However, we
observe one of the structural motifs proposed by James
and Sargueil (SLA) in our MSL structure which forms the
upper helix and loop of SL1 in their model.
SHAPE has proven to be a useful addition to the rep-
ertoire of techniques for probing RNA structure. In
concert with other methodologies its advantages of high
throughput and ability to interrogate each base individu-
ally have provided here, as previously (50), a valuable
additional insight into structure function relationships in
RNA and revealed a potentially critical structural switch
in the viral genomic RNA.
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